NCT06844110View on ClinicalTrials.gov

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor

NARecruitingINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

March 30, 2026

Conditions

Tumor Immunity

Interventions

DRUG

68GA-DOTA-dPNE

Intravenous administration of 68GA-DOTA-dPNE tracer

Trial Locations (1)

100730

RECRUITING

PUMCH, Dongcheng

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER